Stock Groups

AbbVie Earnings, Revenue Beat in Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. AbbVie Earnings, Revenue Beat in Q3

AbbVie reported Friday its third quarter results. They beat the analysts’ estimates and generated more revenue than expected.

AbbVie reported earnings per share at $3.33 for revenue $14.34B. Investing.com polled analysts to predict EPS of 3.22 on $14.3B revenue.

AbbVie shares rose 2% over the first of the year but are down 9.76% from September 1’s 52-week peak of $121.53. They are under-performing the S&P 500 which is up 22.37% from the start of the year.

Following the publication, AbbVie shares rose 1.57% in premarket trade.

AbbVie reports on other earnings from the healthcare sector in this month

AbbVie’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific beat all expectations Wednesday, posting a third quarter EPS (EPS) of $5.76 on revenues of $9.33B compared with EPS forecasted at $4.68 for revenue of $8.33B.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]